Company: INKT
Filing Date: 2025-11-07
Form Type: S-3
Source: 0001193125-25-272532
Chunk: 12

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-11-07
Form: S-3
Chunk 12
---
 of the net proceeds we may receive, and investors will be relying on the judgment of our management regarding the application of our net proceeds. Additional information on the use of net proceeds from the sale of
securities by us under this prospectus may be set forth in the prospectus supplement relating to the specific offering.

8

PLAN OF DISTRIBUTION Our Plan of Distribution We may sell the securities, from time to time, to or through underwriters or dealers, through agents or remarketing firms, or directly to one or more purchasers pursuant to:

| • |     | underwritten public offerings; |

| • |     | negotiated transactions; |

| • |     | block trades; |

| • |     | “at the market offerings,” within the meaning of Rule 415(a)(4) of the Securities Act of 1933, as 
 amended, or the Securities Act, into an existing trading market, at prevailing market prices; or  |

| • |     | through a combination of these methods. |

We may sell the securities to or through one or more underwriters or dealers (acting as principal or agent), through agents, or directly to one or more purchasers. We may distribute securities from time to time in one or more transactions:

| • |     | at a fixed price or prices, which may be changed; |

| • |     | at market prices prevailing at the time of sale; |

| • |     | at prices related to such prevailing market prices; or |

| • |     | at negotiated prices. |

A prospectus supplement or supplements (and any related free writing prospectus that we may authorize to be provided to you) will describe the terms of the offering of the securities, including, to the extent applicable:

| • |     | the name or names of the underwriters, dealers or agents, if any; |

| • |     | if the securities are to be offered through the selling efforts of brokers or dealers, the plan of distribution                                                                                                                                         
 and the terms of any agreement, arrangement, or understanding entered into with broker(s) or dealer(s) prior to the effective date of the registration statement, and, if known, the identity of any broker(s) or dealer(s) who will participate in the 
 offering and the amount to be offered through each;                                                                                                                                                                                                     |

| • |     | the purchase price of the securities or other consideration therefor, and the proceeds, if any, we will receive 
 from the sale;                                                                                                  |

| • |     | if any of